PCI Begins Integration of AndersonBrecon

With the purchase of the AndersonBrecon Group, Packaging Coordinators, Inc. (PCI) adds clinical packaging and cytotoxic high-potency packaging to its commercial contract packaging assets. PCI will have 140 packaging suites, about half of those coming from AndersonBrecon’s facilities in Rockford, IL and Brecon, Wales.
Teams from both sides will be working to combine best practices in a merger that should be completed in the next 90 days, says Bill Mitchell, PCI’s president and ceo.
“We have defined five commitments as an organization—the top two of which are customer focused: We are going to provide the industry’s leading customer experience as well as the industry’s best quality; while remaining flexible and reliable. Our capital plans will reflect what our customers are going to need from us,” Mitchell says.
“Serialization is a big area of investment coming up that we are discussing now with customers. We are well on our way—both the legacy PCI business and AndersonBrecon Group have had plans in place; part of our integration is to synergize those so we have the same offering across the organization. This needs to be executed very quickly,” he adds.
With the merger, PCI is adding “four or five” proprietary compliance package formats to its three legacy formats, creating “a broad spectrum of compliance and child-resistant packaging opportunities and choices,” Mitchell says.
Based in Philadelphia, with leased production space in Woodstock IL, PCI was formed last year with the purchase by venture capital firm Frazier Healthcare and PCI of the US commercial packaging assets of Catalent Pharma Solutions.
The Rockford and Brecon sites will report to PCI chief operating officer Bill Bolding. Bolding worked with Mitchell for 12 years at PCI Packaging Services and then at Cardinal Health, which acquired the first incarnation of PCI in 1996. Cardinal would sell the packaging business to the Blackstone Group and Catalent Pharma Solutions in 2007.
Bob Misher, most recently Anderson Group’s senior vp, clinical packaging and services, will report to Mitchell, as will Phil DiGiacomo, senior vp of sales, and Mark Rose, vp finance.
Mitchell says the merger is a strategic partnership that supports a focus by PCI and Frazier on growing the business. “We have no intention of consolidating facilities--this is not about facility synergies. We will primarily be about organic growth; but without question, we will continue to pursue acquisitions,” he says.
No votes yet